• Buy two copies of Value.able for the price of one this Christmas, and give the gift of learning how to value the best stocks and buy them for less than they’re worth. Discount code: XMASGIFT

2Q2022 Polen Capital Global Small and Mid Cap Commentary

2Q2022 Polen Capital Global Small and Mid Cap Commentary

The second quarter of 2022 echoed themes that started earlier this year. High inflation, rising interest rates, and a general “riskoff” mentality have created some difficulty for our investing style in the Polen Capital Global Small and Mid Cap Fund.

Certain market segments, including consumer discretionary, are under more acute selling pressure given fears about consumer weakness in recessionary periods. Another notable feature of the investment backdrop has been the outperformance of cyclical sectors, energy being the best example. With the Polen Capital focus on what they believe to be high-quality compounders over the long term, companies in this space tend not to fit their investment criteria.

The top absolute contributors to the Fund’s performance over the second quarter included Azenta US Inc. which is a a life science sample management business, Dechra Pharmaceuticals – a U.K based animal health care company, and the company that operates the Toronto stock exchange TMX Group Limited. The most significant absolute detractors from performance included the digitally native information technology service business Globant S.A., e-commerce fashion company Revolve Group, and a leading global IT consulting business Endava PLC.

Polen Capital continue to research and own companies where they believe the Polen Capital flywheel framework is intact and risk-adjusted returns are compelling. Polen Capital are taking advantage of new opportunities in companies that they believe are attractive alternatives but did not previously meet their expected internal rate-of-return (IRR) hurdle. This includes some health care companies that have been on our watch list for years.

Read the Polen Capital Global Small and Mid Cap 2Q2022 update

INVEST WITH MONTGOMERY

Established in 1979, Polen Capital is a high conviction growth investment manager with offices in the US and UK. Polen has been dedicated to serving investors by providing concentrated portfolios of the highest-quality companies for more than three decades. The firm’s established team manages US$71 billion in total assets and their longest-running flagship investment strategy has delivered on average double digit annual returns for more than 30 years.

This post was contributed by a representative of Montgomery Investment Management Pty Limited (AFSL No. 354564). The principal purpose of this post is to provide factual information and not provide financial product advice. Additionally, the information provided is not intended to provide any recommendation or opinion about any financial product. Any commentary and statements of opinion however may contain general advice only that is prepared without taking into account your personal objectives, financial circumstances or needs. Because of this, before acting on any of the information provided, you should always consider its appropriateness in light of your personal objectives, financial circumstances and needs and should consider seeking independent advice from a financial advisor if necessary before making any decisions. This post specifically excludes personal advice.

Why every investor should read Roger’s book VALUE.ABLE

NOW FOR JUST $49.95

find out more

SUBSCRIBERS RECEIVE 20% OFF WHEN THEY SIGN UP


Post your comments